<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Kinase requirements human cells: II. Genetic <br /> interaction screens identify kinase requirements <br /> following HPV16 E7 expression cancer cells <br />  <br />  <br /> Human papillomavirus (HPV) oncoproteins subvert cellular signaling            vates tumor suppressor protein p53 accelerating pathways, including kinase pathways, carcinogenic pro-             degradation proteasome, HPV E7 <br /> cess. identify kinases targeted HPV16 E7 oncoprotein,               protein inactivates retinoblastoma tumor suppressor protein <br /> shRNA kinase screens performed RKO colorectal carcinoma               pRb related p107/p130 family members similar <br /> cell lines differ expression HPV16 E7. screens      mechanism. addition, high-risk HPV E6 E7 oncoproteins <br /> identified kinases essential survival RKO cells,     number additional cellular targets contribute essential RKO cells expressing HPV16 E7. kinases include        oncogenic activities (reviewed ref. 4). <br /> CDK6, ERBB3, FYN, AAK1, TSSK2.  predicted,                   p53 pRb tumor suppressor pathways commonly <br /> CDK6 knockdown inhibits pRb phosphorylation induces S-phase               rendered dysfunctional human carcinomas, depletion, inhibiting cell viability. Knockdown ERBB3, FYN, <br />                                                                               inactivation high-risk HPV E6 E7 proteins generates AAK1, TSSK2 induces similar loss cell viability                                                                               functional equivalent loss p53 pRb mutation. RKO <br /> unknown mechanism. Expression HPV16 E7 oncoprotein, <br />                                                                               colon carcinoma cell line used intact pRb p53 tumor <br /> known bind degrade pRb, relieves requirement                                                                               suppressor pathways, previous work shown pRb <br /> kinases. studies demonstate expression single onco- <br /> protein dramatically alter kinase sensitivity human cells.                                                                               functions lost RKO cells express HPV16 E7 (RKO <br /> shRNA screens used perform analogously genetic interaction            E7) (5). <br /> screens commonly used genetically tractable organisms                 anticipate different nuances emerge <br /> yeast, represent exciting method unbiased identifi-           time, human cells used behave cation cellular signaling pathways targeted cancer mutations.           way yeast cells simple genetic screens. reported                                                                               preceding study (6), numerous differences kinase <br /> essential kinases &#229;&#8230;&#169; shRNA screening &#229;&#8230;&#169; E7 oncoprotein &#229;&#8230;&#169;                        requirements analyzed wide range human tumor <br /> retinoblastoma tumor suppressor                                               cell lines. somewhat expected, interesting note <br />                                                                               kinase requirements quite similar cells                                                                               tissue type cell lines differ expression E   xpression oncoprotein loss tumor suppressor <br />     protein known changes provide essential steps development cancer. understand                                                                               single protein. Specifically, kinase requirements                                                                               RKO colorectal carcinoma cells expressing HPV16 E7 phenotypic changes induced activation               oncoprotein compared RKO parental cells, studied oncogenes loss tumor suppressor genes                  observed distinct subset kinases differentially <br /> (reviewed ref. 1). cases, molecular consequences                required (6). findings prompted characterize tumorigenic events determined, studies               greater differential kinase requirements cancer cells limited recording changes primarily path-               differed expression HPV16 E7 oncoprotein. <br /> ways proteins shown act.              CDK6, ERBB3, FYN, AAK1, TSSK2 identified difficult comprehensively determine molecular alterations              essential kinases RKO cells dispensable viability induced specific oncogenic events. potential                  RKO E7 cells. differential requirement CDK6 RKO <br /> approach determine cells altered expression               versus RKO E7 cells likely reflects ability HPV16 E7 <br /> oncoprotein loss tumor suppressor protein unbiased,             target pRb tumor suppressor protein degradation. comprehensive way, use comparative RNAi                        ERBB3, FYN, AAK1, TSSK2 represent previously <br /> screens. RNAi screens perceived genetic inter-                 unidentified essential regulators pRb activity RKO cells, action screens action RNAi knockdown                   kinases rendered dispensable RKO E7 viability <br /> analyzed combination action cancer-promoting               consequence HPV16 E7 targeting signal transduction <br /> event.  report proof principle genetic interaction               pathways cells. results suggest general method screen human cells action human papil-                 study changes cellular signaling networks induced lomavirus (HPV) 16 E7 oncoprotein studied conjunction                   cancer-promoting event, specifically expression single kinase loss function RNAi screen. <br />    High-risk HPVs causative agents cervical carcinoma, leading cause death women, worldwide. number                 Author contributions: B., E.H., K.M., D G. designed research; B., W.L., M.G., anogenital tract carcinomas, fraction oropharyngeal                  D G. performed research; B., J.P., D G. contributed new reagents/analytic tools; <br /> carcinomas, associated high-risk HPV infections                 B., W.L., D G. analyzed data; B., E.H., K.M., D G. wrote paper. <br /> (reviewed (2, 3)). High-risk HPV E6 E7 proteins                    authors declare conflict  <br /> consistently expressed cervical cancers, expression                 correspondence addressed. E-mail: eharlow@hms.harvard.edu. necessary induction maintenance transformed                 article contains supporting information online www.pnas.org/cgi/content  <br /> state. functional roles HPV E6 E7 proteins                0806195105/DCSupplemental. studied extensively. high-risk HPV E6 protein inacti-                &#194;&#169; 2008 National Academy Sciences USA <br />  <br />  <br />  <br /> 16478 &#226;&#8364;&#8220;16483 &#229;&#8230;&#169; PNAS &#229;&#8230;&#169; October 28, 2008 &#229;&#8230;&#169; vol. 105 &#229;&#8230;&#169;  43                                                       www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0806195105 <br />                                                                                       knockdown cell lines. Differential kinase require- <br />                                                                                      ments resulting expression HPV16 E7 oncoprotein <br />                                                                                      RKO cells distinguished. Knockdowns 19 unique <br />                                                                                      kinases induced 30% greater differential cell survival <br />                                                                                      RKO RKO E7 cells  Fig. 1). complete list <br />                                                                                      detailing percentage loss cell viability resulting <br />                                                                                      survival differentials RKO versus RKO E7 cells                                                                                      supporting information (SI) Table S1. results demon- <br />                                                                                      strate shRNA screens used determine specific <br />                                                                                      differences cellular kinase requirements induced expres- <br />                                                                                      sion HPV16 E7 oncoprotein. <br />  <br />                                                                                      HPV16 E7 Expression Rescues Lethality Kinase Loss. verify <br />                                                                                      explore differential kinase requirements identified                                                                                      initial screen, chose investigate 8 19 <br />                                                                                      kinases exhibiting largest survival differentials RKO <br />                                                                                      versus RKO E7 cells. addition, kinases exhibiting                                                                                      significant survival differentials cell popula- <br />                                                                                      tions included negative controls.  minimize                                                                                      chance cell survival differentials result                                                                                      target effects, tested shRNAs original <br />                                                                                      RNAi Consortium library targeting selected kinases. <br />                                                                                      kinases tested, identified multiple <br />                                                                                      shRNAs resulted &#226;&#172;&#381;30% survival differential.                                                                                      kinases include CDK6, ERBB3, FYN, AAK1, TSSK2.                                                                                      remaining kinases, TLK1, JNK3, Cke1, did pass <br />                                                                                      validation step consequently included                                                                                      analysis. available shRNAs targeting                                                                                      control kinases exhibited differential killing RKO <br />                                                                                      RKO E7 cells (data shown). <br />                                                                                         Second, performed time course kinase knockdown <br />  <br />  <br />  <br />  <br />                                                                                                                                                                 APPLIED BIOLOGICAL <br />                                                                                      using multiple shRNAs targeting kinases  <br />  <br />  <br />  <br />                                                                                                                                                                      SCIENCES <br /> Fig. 1. Expression HPV16 E7 oncoproteins alters essential kinase          passed validation step. Cells assayed survival <br /> signature RKO colorectal carcinoma cells. RKO RKO E7 cells               using Alamar blue 1, 3, 5, 8 days infection infected 100 lentiviral shRNA expression vectors targeting 80           shRNA lentiviruses, subsequently fixed stained <br /> unique kinases subsequently assessed cell viability using Alamar        crystal violet microscopic evaluation. 5-day time- <br /> blue. Percentage viability determined normalization scram-         point determined optimal determining cell survival <br /> bled shRNA control vector. Results independent shRNA screens,                                                                                      differentials, Alamar blue readings exhibited maximal differ- <br /> performed quadruplicate, represented heat map. column <br /> represents cell line, row represents individual hairpin (hairpin names <br />                                                                                      ences signal overcrowding cells  Rep- given right). Green indicates cell viability red indicates   resentative photomicrographs cells 5 days infection cell viability. Data sorted using unsupervised clustering          shRNAs targeting kinases shown <br /> Euclidean distance.                                                                  demonstrate cell survival differentials consistent                                                                                      Alamar blue measurements (Fig. 2A). shRNAs <br />                                                                                      dramatically inhibited growth RKO cells markedly <br /> oncoprotein, establishes reliable method functional                      affecting proliferation RKO E7 cells. <br /> pathway mapping human cells.                                                          used range viral multiplicities infection deliver <br />                                                                                      varying doses shRNAs cells. Infections performed <br /> Results                                                                              using dilutions viral supernatants, 1.25 20 &#226;&#65533;&#174;l, cells <br /> Expression HPV16 E7 Oncoprotein Induces Differential Kinase                   assayed Alamar blue cell viability 5 days infection. <br /> Requirements Cancer Cells. determine differential kinase                       Percentage reduction cell viability resulting kinase <br /> requirements induced expression HPV16 E7 onco-                             knockdown calculated normalization scrambled <br /> protein, performed essential kinase screens RKO                       shRNA control. Cell viability values graphed shRNA <br /> parental cell line RKO cells stably expressing HPV16 E7                          multiple viral concentrations. Red lines squares indicate <br /> (RKO E7) (5). cell lines infected lentiviral                          percentage loss cell viability RKO E7 cells blue lines <br /> vectors expressing 100 individual shRNAs targeting 80 unique                         circles indicate percentage loss cell viability RKO <br /> kinases. correspond 100 kinase &#226;&#8364;&#732;&#226;&#8364;&#732;hits&#226;&#8364;&#8482;&#226;&#8364;&#8482;                    control cells. Fig. 2  results shRNAs targeting <br /> essential viability HeLa 293T cells, identified                 different portions kinase shown (Fig. 2B). primary screen (6). Cells subsequently assayed viability                    shRNAs inhibited proliferation RKO control cells &#226;&#172;&#381;30% <br /> 5 days infection. Percentage cell viability determined                  RKO E7 cells. <br /> using Alamar blue, dye measures mitochondrial fitness (7,                        final validation step, assessed kinase mRNA <br /> 8). Values calculated percentage loss viability,                     knockdown 60 h infection RT-PCR, normalizing normalized scrambled control shRNA. independent                             values GAPDH mRNA levels. control, included <br /> screens performed, quadruplicate, resulting                      shRNAs ALK, kinase did demonstrate correlation coefficient screens 0.95. Kinase signa-                       significant percentage survival differential RKO tures screens displayed heat map; green                           RKO E7 cells. TSSK2 mRNA levels adequately <br /> denotes greatest cell viability, red denotes cell                  assessed, identify effective primer pairs. <br /> viability (Fig. 1). column represents data specific                      Percentage RNA knockdown calculated shown cell line, row illustrates results individual kinase                   Fig. 2C. GAPDH levels measured report cell <br />  <br /> Baldwin et al.                                                                                         PNAS &#229;&#8230;&#169; October 28, 2008 &#229;&#8230;&#169; vol. 105 &#229;&#8230;&#169;  43 &#229;&#8230;&#169; 16479 <br />  Fig. 2. HPV16 E7 expression abrogates requirement CDK6, ERBB3, FYN, AAK1, TSSK2 viability RKO cells.   Photomicrographs RKO RKO E7 cells infection different shRNA expression vectors targeting kinase. Cells fixed stained crystal violet 5 days infection. (B) Viability RKO RKO E7 cells infection different concentrations shRNA expression vectors. Cells infected 1.25 20 &#226;&#65533;&#174;l corresponding shRNA expression vector assayed Alamar blue cell survival 5 days infection. Percentage loss cell viability resulting kinase knockdown graphed. Values normalized scrambled hairpin control. Red lines squares indicate values RKO E7 cells, blue lines circles indicate values RKO control cells. Results hairpins targeting different portions kinase shown. (C) Efficiency kinase mRNA <br /> knockdown RKO RKO E7 cells. Quantitative RT PCR analysis used determine expression kinase 60 h infection corresponding <br /> shRNA expression vectors. Values shown normalized GAPDH levels. <br />  <br />  <br />  <br /> fitness, relative mRNA levels of kinases                     pRb function compromised HPV16 E7- <br /> RKO RKO E7 cells measured (Fig. S1). GAPDH                            mediated degradation (5). Given differential requirement mRNA levels did change significantly viral infection,                     CDK6 RKO RKO E7 cells, postulated arguing change kinase mRNA levels adversely                      CDK6 knockdown, RKO cells undergo G1/S cell cycle <br /> affect overall cellular viability (Fig. S1 . overall                   arrest, RKO E7 cells continue progress endogenous mRNA levels kinases tested RKO cells,                         cell cycle. test hypothesis, cell cycle profiles ALK, CDK6, FYN kinase levels did vary greatly E7                       determined CDK6 knockdown cell lines. expression.  relative endogenous mRNA levels                             tested shRNAs targeting ERBB3 included shRNAs <br /> AAK1 ERBB3 approximately fivefold E7                              targeting JNK3, differentially affect viability expression  Fig. S1B). Taken  experiments                        RKO RKO E7 cells, negative control. Cells demonstrate HPV16 E7 complement requirement                            collected 96 h infection FACS analysis, resulting CDK6, ERBB3, FYN, AAK1, TSSK2 RKO colorectal                              profiles shown (Fig. 3). RKO cells expressing E7 <br /> carcinoma cells.                                                                    oncoprotein, change cell cycle profiles detected <br />                                                                                     CDK6 ERBB3 knockdown  Fig. 3 Lower). S-Phase Depletion Induced Kinase Knockdown Prevented                       contrast,  observed striking reduction S-phase <br /> Expression HPV16 E7. action CDK6 cell                      CDK6 ERBB3 knockdown RKO cells. expected, <br /> cycle phosphorylation pRb extensively                           JNK3 knockdown did affect cell cycle profiles RKO <br /> studied known (reviewed ref. 9), sought                        RKO E7 cells  Fig. 3). results indicate compare effects CDK6 knockdown cell cycle                          expression HPV16 E7 oncoprotein abrogates cell cycle <br /> RKO cells, contain functional pRb, RKO E7 cells,                          perturbations induced loss CDK6 ERBB3. <br />  <br /> 16480 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0806195105                                                                                                   Baldwin et al. <br />                                                                                                            Fig. 3. HPV16 E7 expression RKO cells <br />                                                                                                           abrogates S-phase depletion induced                                                                                                           CDK6 ERBB3 knockdown. RKO RKO <br />                                                                                                           E7 cells infected shRNA ex- <br />                                                                                                           pression vectors targeting CDK6, ERBB3,                                                                                                           JNK3 scrambled shRNA control vector. <br />                                                                                                           Cells harvested 96 h infection, <br />                                                                                                           stained propidium iodide, DNA  <br />                                                                                                           tent analyzed FACS. Percentage                                                                                                           cells S-phase given. Data shown repre- <br />                                                                                                           sentative independent experiments. <br />  <br />  <br />  <br /> CDK6 Depletion Reduces pRb Phosphorylation. Given striking         panels siRNAs shRNAs, provide approaches closely <br /> reduction S-phase response CDK6 knockdown RKO              resemble genetic screens mammalian tissue culture cells (11, <br /> cells, CDK6&#226;&#8364;&#8482;s known function phosphorylate pRb               12). studies reported  performed equivalent <br /> viewed ref. 9), sought determine CDK6                 genetic interaction screen determined expression <br /> knockdown altered phospho-pRb levels RKO cells. phos-             HPV16 E7 oncoprotein changed patterns kinase <br /> pho-specific antibody used analyze pRb phosphorylation          requirements colon carcinoma cell line. preceding study serines 807 811, previously identified        (6), report comparison essential kinase signatures CDK4/CDK6-preferred phosphorylation sites (10). RKO RKO E7 cells infected shRNAs targeting CDK6 <br />  <br />  <br />  <br />  <br />                                                                                                                                                             APPLIED BIOLOGICAL scrambled shRNA control. Cells lysed Western analysis 96 h infection. Samples analyzed  <br />  <br />  <br />  <br />                                                                                                                                                                  SCIENCES <br /> total pRb, phosphoserine 807/811-pRb, tubulin, CDK6, E7 <br /> levels using Kodak Imager (Fig. 4A). Total pRb phospho- <br /> serine 807/811-pRb levels normalized tubulin loading <br /> control, relative protein levels CDK6 knockdown calculated percentage control. Phosphoserine 807/811- <br /> pRb levels (P-Rb, gray bars) fraction total pRb levels <br /> (Total Rb, black bars) calculated indicated (Fig. <br /> 4B). ratios phosphoserine 807/811-pRb expected: <br /> CDK6 knockdown reduces phosphoserine 807/811-pRb levels RKO cells. <br />  <br /> Discussion <br /> Mammalian cell biology limited absence methods perform genetic screens immensely <br /> powerful genetically tractable model systems. Components mammalian signal transduction pathways commonly identi- <br /> fied number approaches, including protein purification, <br /> homologies model systems, reverse genetics ap- <br /> proaches, interesting genes identified cloning disease genes. Proteins identified using approaches linked molecular machines sizes identifying associated <br /> proteins integration signaling pathways finding <br /> immediate upstream downstream partners. Additionally, roles contributing general cellular phenotypes inferred analyzing affect cell behavior levels activities altered, determining subcellular localization comparison proteins  methods provided basis views modern mammalian cell biology.  pow- <br /> erful addition tools able use genetic-type screens   Fig. 4. HPV16 E7 expression RKO cells prevents reduction phsopho pRb <br />                                                                        levels CDK6 knockdown.   Immunoblot analysis phospho pRb (Ser mammalian cells. saturation, genetic screens           807/811) total pRb levels RKO colorectal carcinoma cells 72 h provide list approaches unbiased comprehen-          infection CDK6 specific shRNA expression vectors scrambled shRNA <br /> sive compendium genes play roles particular process       control vector. CDK6, E7 &#226;&#65533;&#163;-tubulin levels shown. (B) Relative levels affect action proteins.        total pRb (black) versus phospho-pRb (Ser 807/811) (gray) CDK6 <br /> commented previously RNAi screens, various              knockdown quantified using Kodak Imager. <br />  <br />  <br /> Baldwin et al.                                                                             PNAS &#229;&#8230;&#169; October 28, 2008 &#229;&#8230;&#169; vol. 105 &#229;&#8230;&#169;  43 &#229;&#8230;&#169; 16481 <br />  tumor cell lines carry various mutations acquired cells     mRNA RKO E7 reflect fact expression carcinogenesis. Initially, expected experiments    essential viability cells. steady enable correlate specific alterations essential kinase   state mRNA levels AAK1 ERBB3 reduced RKO <br /> signatures defined oncogenic mutations common            E7 cells, present levels sufficient observe cancer lines.  resulting kinase signatures highly      decrease specific shRNA expression  Fig. 2C). <br /> complex, presumably reflect different                CDK6&#226;&#8364;&#8482;s role directly phosphorylating pRb G1/S phase <br /> cellular variations acquired tumor development adap-         transition cell division cycle established (reviewed tation culture.  compared cell lines            ref. 9);  tested CDK6 knockdown RKO <br /> differed expression single oncoprotein, HPV16 E7,      cells affected cell cycle progression. predicted, CDK6 knock- <br /> differences kinase requirements fewer relatively            blocked RKO cells entering S phase concomitant <br /> straightforward discern (6).                                         decrease pRb phosphorylation serine residues 807 811 <br />    work reported  compared established                 Figs. 3 4). results argue CDK6 obligatory <br /> colorectal carcinoma cell line, RKO, derivative ex-           function regulation G1/S transition RKO cells presses HPV16 E7 oncoprotein, RKO E7. total 80            function abrogated RKO E7 cells, presumably kinases evaluated study, initial screen           HPV16 E7-mediated degradation pRb family members. tentatively identified 19 kinases essential viability        exquisite sensitivity RKO cells CDK6 knockdown somewhat <br /> parental RKO line dispensable viability RKO E7 cells.        surprising CDK4 generally thought provide redun- <br /> Somewhat surprisingly, screen did identify kinases         dancy CDK6 pRb phosphorylation.  evidence showed synthetic lethal interaction HPV16 E7                kinases entirely functionally redundant expression RKO cells. results suggest cellular    distinct overlapping functions reported previous <br /> background, subversion cellular signaling pathways targeted          studies (13&#226;&#8364;&#8220;17). results described support notion HPV16 E7, pRb pathway, induce new              CDK4 provide limited redundancy CDK6 loss sensitive points relieve existing rate-limiting steps.       RKO cells. consistent pRb&#226;&#8364;&#8482;s role inhibitor                Similar observed CDK6, ERBB3 knockdown <br /> proliferation pRb family member&#226;&#8364;&#8482;s ability act number        causes S-phase depletion RKO cells, lesser key transcription steps, making unlikely event       extent RKO E7 cells  Fig. 3). ERBB3 member sufficient overcome large number important           EGF receptor tyrosine kinase family directly involved <br /> pRb/p107/p130 regulated events.                                         pRb phosphorylation. Nonetheless, expression cyclin D1,    80 kinases evaluated study originally       regulatory subunit CDK4 CDK6, regulated growth <br /> identified essential viability HeLa 293T cells,    factor signaling (18), conceivable ERBB3 expect HeLa RKOE7 cells respond                    knockdown RKO cells indirectly affect CDK6 activity similarly essential kinase screens, cancer     pRb phosphorylation. Alternatively, ERBB3 cell lines express high-risk HPV E7. cell lines     modulate signal transduction pathways involved did respond similarly majority kinases tested, did       G1/S cell cycle transition abrogated HPV16 E7 <br /> observe subset kinases essentiality altered           expression mechanisms pRb inactivation. <br /> HPV16 E7 expression compared RKO parental cells             possibility supported finding ERBB3 <br /> HeLa cells. differences kinase requirements              knockdown results dramatic increase cells subG1 <br /> observed RKO E7 versus HeLa cells             DNA content, suggestive apoptotic cell death, CDK6 E6 expression RKO E7 cells,                knockdown did effect. <br /> observing effects solely result E7 expression. Alterna-           HPV16 E7 expression RKO cells likewise rescue loss tively, differences kinase essentiality caused       viability consequence FYN, AAK1, TSSK2 knock- <br /> differences genetic background cells. important       know related ability note kinases targeted E7 oncoprotein RKO cells        HPV16 E7 target pRb family members different identified assayed           reflects inactivation cellular HPV16 E7 targets (Fig. 5). cancer cell lines primary epithelial cells.                    proof concept experiments reported    initial list 19 kinases tentatively            provide evidence unbiased shRNA screens produc- <br /> identified primary screen, subset 8 kinases showed     tively used determine cellular signal transduction path- dramatic survival differentials RKO versus RKO E7           ways change carcinogenesis.  demonstrate <br /> cells chosen detailed follow         shRNA screens reveal changes kinase requirements <br /> kinases, tested multiple shRNAs targeting different regions          resulting expression single oncoprotein. Previous respective mRNA. qualify detailed studies,           methods effective identifying cancer mutations similar cell survival differentials detected      characterizing corresponding oncoproteins tumor sup- shRNAs targeting kinase. kinases            pressor proteins. approach exemplified provides tested, kinases, CDK6, ERBB3, AAK1, TSSK2,                practical method identify major cellular changes occur <br /> FYN, continued score multiple shRNAs, demonstrating             immediate biochemical alterations caused consistent robust responses similar observed          cancer mutations  Genetic interaction screens  initial screen. shRNAs inhibited proliferation       formed closely related cellular backgrounds raise possi- RKO cells showed concomitant decreases target kinase         bility identifying essential proteins requirements mRNA protein levels  Figs. 2 C 4A).              induced action distantly acting oncoprotein tumor <br /> interesting note relative endogenous mRNA levels         suppressor. proteins difficult identify AAK1 ERBB3 reduced approximately fivefold RKO                standard biochemical methods. interesting deter- <br /> E7 cells compared RKO control cells. Conversely,              newly identified protein kinases wired endogenous mRNA levels CDK6 FYN, addition                  molecular targets HPV16 E7 useful <br /> CDK6 protein levels, significantly vary          therapeutic cancer targets. <br /> cell lines  Fig. 4A Fig. S1B). results demonstrate decreased sensitivity knockdown kinases         Materials Methods consequence high-level expression RKO E7 cells.             Tissue Culture. RKO cells stably expressing pcDNA3 control vector HPV16  observed reduced expression AAK1 ERBB3               E7 described ref. 5 maintained McCoy&#226;&#8364;&#8482;s medium <br />  <br />  <br /> 16482 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0806195105                                                                                    Baldwin et al. <br />                                                                                                6 plates 72 h infection Western analysis 96 h                                                                                               infection cell cycle analysis. <br />  <br />                                                                                               Alamar Blue Assay. days infection, media removed                                                                                               96 plates, 100-&#226;&#65533;&#174;l Alamar blue reagent (Biosource/ <br />                                                                                               Invitrogen, diluted 10-fold supplemented McCoy&#226;&#8364;&#8482;s medium) added                                                                                               (7, 8). Plates incubated 2 4 h 37&#194;&#176;C read 595 nm <br />                                                                                               microtiter plate reader, Spectrafluor Plus (Tecan). Raw values                                                                                               normalized scrambled control. <br />  <br />                                                                                               Crystal Violet Staining. days infection, media removed                                                                                               96 plates. Cells washed PBS fixed 20 min <br />                                                                                               10% <span id='am-1' about='obo:IMR_0200208' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-2' property="oboInOwl:hasDbXref" content="KEGG:C00033" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="Acetic acid" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0200208" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>acetic acid</span> 10% methanol. Cells washed PBS, <br />                                                                                               incubated 30 min 0.4% crystal violet 20% ethanol,                                                                                               subsequently washed PBS twice. Phase contrast Images acquired <br />                                                                                               inverted microscope magnification 100&#226;&#171;&#187; (Nikon). <br />  <br />                                                                                               Cell Cycle Analysis. Infected cells trypsinized centrifuged Fig. 5. Kinases required survival RKO cells act upstream Rb.               media, washed PBS. washing, cells resuspended 0.5 ml <br /> CDK6, ERBB3, FYN, AAK1, TSSK2 necessary survival RKO                       PBS. Cells fixed adding 0.5 ml 80% ethanol incubated colorectal carcinoma cells. requirement relieved expression                 4&#194;&#176;C overnight. fixation, cells washed PBS resuspended HPV16 E7 oncoprotein subsequent reduction Rb levels. CDK6 loss                         200 &#226;&#65533;&#174;l 0.5 mg/ml RNAseA PBS. incubation 37&#194;&#176;C 30 min, 200 <br /> inhibits phosphorylation Rb, induces S-phase loss, decreases cell sur-                 &#226;&#65533;&#174;l 70-&#226;&#65533;&#174;M propidium iodide 38-mM sodium citrate, pH 7.3, added vival. Knockdown ERBB3, FYN, AAK1, TSSK2 results similar loss                  incubated 37&#194;&#176;C additional 30 min. Cells stored 4&#194;&#176;C overnight <br /> cell survival unknown mechanism. kinases function                        analyzed FACS Calibur (Becton Dickinson). direct indirect action Rb protein alternatively cell cycle control pathways subverted HPV16 E7 expression.                  Western Analysis. Cells scraped RIPA buffer containing protease inhibitor <br />                                                                                               mixture (Roche) 25 mM NEM. Fifty-microliter samples prepared 5&#226;&#171;&#187; <br />                                                                                               SDS loading buffer, resolved 4 12% Nupage bis-Tris gradient gels (Invitro- <br /> supplemented 10% calf serum, 100 units/ml penicillin, 100 &#226;&#65533;&#174;g/ml strep-                   gen), transferred PVDF membrane (Perkin&#226;&#8364;&#8220;Elmer). Antibodies: ErbB3 <br /> tomycin, 0.5 mg/ml G418 (19).                                                             (1B2 Cell Signaling), Rb (M-153 Santa Cruz), phospho-Rb (Ser-807/811 <br />                                                                                               Cell Signaling), alpha-tubulin (Sigma), CDK6 (DCS83 Cell Signaling), <br /> 100 &#226;&#8364;&#732;&#226;&#8364;&#732;Hits&#226;&#8364;&#8482;&#226;&#8364;&#8482; DNA Virus Production. High quality DNA preparations 100                  HPV 16 E7  mixture 8C9 Zymed ED17 Santa Cruz), antirabbit <br />                                                                                               antimouse HRP conjugates (GE Healthcare). Images captured  <br />  <br />  <br />  <br />                                                                                                                                                                                                 APPLIED BIOLOGICAL <br /> &#226;&#8364;&#732;&#226;&#8364;&#732;hits&#226;&#8364;&#8482;&#226;&#8364;&#8482; obtained using large-scale plasmid purification kit (Qiagen). high-throughput lentiviral production 96 format, 293T packaging                     quantified Kodak 4000R digital imager. <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                      SCIENCES <br /> cells cotransfected shRNA-encoding replication deficient viral vec- <br /> tors necessary helper plasmids virus production. virus                    RT-PCR. Lentiviral vectors expressing specific shRNAs produced RKO <br /> pseudotyped envelope glycoprotein vesicular stomatitis virus                    RKO E7 cells infected described 96 format. RNA <br /> (VSV-g), previously described (20 &#226;&#8364;&#8220;22).                                                    isolated using RNeasy 96 Kit (Qiagen) 36 60 h time points                                                                                               infection. cDNA synthesis performed using SuperScript III Reverse <br /> Infections 96 6 Formats. cell survival assays, RKO RKO               Transcriptase Kit (Invitrogen) 5 &#226;&#65533;&#174;l RNA. Primer-probe sets  <br /> E7 cell lines seeded 96 plates 2,200 cells               signed using Assay Design Center Roche. Gene specific primers using final volume 50 &#226;&#65533;&#174;l  FACS Western analysis, cells               obtained Integrated DNA Technologies, gene specific probes                                                                                               obtained Roche. Real-time PCR reactions performed duplicate seeded 6 dishes 30% confluency final volume 1.5 ml                                                                                               96 format using LightCycler 480 (Roche).  hours plating, viral supernatants added (ranging amounts 1.25 20 &#226;&#65533;&#174;l 96 format, 150 250 &#226;&#65533;&#174;l 6 format), presence 8 &#226;&#65533;&#174;g/ml Polybrene. Plates centrifuged                 1,178 &#226;&#171;&#187; g 22 min. Media replaced 12 h infection. cell <br />                                                                                              <br /> survival assays, 2 &#226;&#65533;&#174;g/ml puromycin added 96 plates.             <br /> Cells harvested 5 days infection 96 plates Alamar blue               <br /> measurements crystal violet image acquisition. Cells harvested                   <br /> </body></html>